期刊
EMBO REPORTS
卷 14, 期 3, 页码 276-283出版社
WILEY
DOI: 10.1038/embor.2013.4
关键词
cAMP; cyclic nucleotide phosphodiesterase; PDE; beta-adrenergic receptor; antagonist
资金
- Fondation Leducq [06CVD02 cycAMP]
- National Institutes of Health [HL0927088, HL107960]
It is generally assumed that antagonists of G(s)-coupled receptors do not activate cAMP signalling, because they do not stimulate cAMP production via G(s)-protein/adenylyl cyclase activation. Here, we report a new signalling pathway whereby antagonists of beta(1)-adrenergic receptors (beta(1)ARs) increase cAMP levels locally without stimulating cAMP production directly. Binding of antagonists causes dissociation of a preformed complex between beta(1)ARs and Type-4 cyclic nucleotide phosphodiesterases (PDE4s). This reduces the local concentration of cAMP-hydrolytic activity, thereby increasing submembrane cAMP and PKA activity. Our study identifies receptor/PDE4 complex dissociation as a novel mechanism of antagonist action that contributes to the pharmacological properties of beta(1)AR antagonists and might be shared by other receptor subtypes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据